Aragon Pharmaceuticals Receives $49,999,988 Series D Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fe7be6dc-b304-4064-9684-2cd848d3c768&Preview=1 - Date
9/26/2012 - Company Name
Aragon Pharmaceuticals - Mailing Address
12780 El Camino Real San Diego, CA 92130 - Company Description
Aragon Pharmaceuticals is a San Diego based biopharmaceutical company focused on developing a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. - Website
http://www.aragonpharmaceuticals.com - Transaction Type
Venture Equity - Transaction Amount
$49,999,988 - Transaction Round
Series D - Proceeds Purposes
This financing combined with our raise earlier this year provides Aragon with the resources to advance our pipeline, including ARN-509 for which we just recently announced promising Phase II results in prostate cancer patients. - M&A Terms
- Venture Investor
venBio - Venture Investor
Topspin Partners - Venture Investor
OrbiMed Advisors - Venture Investor
Aisling Capital - Venture Investor
The Column Group
